Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17826 | 580 | 44.5 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
328 | 3 | PHOSPHOLIPASE D//STIM1//REGUCALCIN | 38118 |
1486 | 2 | PROTEIN KINASE C//BRYOSTATIN//BRYOSTATIN 1 | 7631 |
17826 | 1 | BRYOSTATIN//BRYOSTATIN 1//APLYSIATOXIN | 580 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BRYOSTATIN | authKW | 2948119 | 14% | 67% | 84 |
2 | BRYOSTATIN 1 | authKW | 2832394 | 14% | 68% | 79 |
3 | APLYSIATOXIN | authKW | 303331 | 2% | 52% | 11 |
4 | BRYOSTATIN I | authKW | 210584 | 1% | 100% | 4 |
5 | MARINE BRYOZOAN | authKW | 198428 | 1% | 54% | 7 |
6 | BUGULA NERITINA | authKW | 181556 | 2% | 27% | 13 |
7 | BRYOSTATIN 11 | authKW | 157938 | 1% | 100% | 3 |
8 | APLOG 1 | authKW | 105292 | 0% | 100% | 2 |
9 | D ISOBUTYL LACTATE | authKW | 105292 | 0% | 100% | 2 |
10 | DABIS MALEATE | authKW | 105292 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1872 | 30% | 0% | 176 |
2 | Chemistry, Organic | 818 | 18% | 0% | 105 |
3 | Hematology | 542 | 10% | 0% | 58 |
4 | Chemistry, Medicinal | 365 | 8% | 0% | 47 |
5 | Pharmacology & Pharmacy | 270 | 15% | 0% | 86 |
6 | Chemistry, Multidisciplinary | 104 | 12% | 0% | 67 |
7 | Immunology | 43 | 6% | 0% | 35 |
8 | Medicine, Research & Experimental | 20 | 3% | 0% | 20 |
9 | Biochemistry & Molecular Biology | 17 | 9% | 0% | 55 |
10 | Plant Sciences | 11 | 4% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REGA MED MICROBIOL IMMUNOL | 105292 | 0% | 100% | 2 |
2 | INTERNAL MEDKARMANOS CANC | 78966 | 1% | 50% | 3 |
3 | BARTH LONDON | 52646 | 0% | 100% | 1 |
4 | CANC UK MED ONCOLCLIN TRIALS UNIT | 52646 | 0% | 100% | 1 |
5 | CHEM BIOL MASS SPE OMETRY IL | 52646 | 0% | 100% | 1 |
6 | CHRISTIE CANC | 52646 | 0% | 100% | 1 |
7 | COLUMBIA P BYTERIAN COMPREHENS CANC | 52646 | 0% | 100% | 1 |
8 | DRUG SCREENINGSHANGHAI BIOL SCI | 52646 | 0% | 100% | 1 |
9 | HEMATOL ONCOL HEMATOL ONCOL | 52646 | 0% | 100% | 1 |
10 | J AN SOC PROMOT SCI DC2 ORGAN CHEM LIFE SCI | 52646 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INVESTIGATIONAL NEW DRUGS | 3467 | 2% | 1% | 13 |
2 | MOLECULAR AND CELLULAR DIFFERENTIATION | 2391 | 0% | 5% | 1 |
3 | ENZYME & PROTEIN | 2336 | 0% | 2% | 2 |
4 | ORGANIC LETTERS | 1477 | 5% | 0% | 27 |
5 | JOURNAL OF NATURAL PRODUCTS | 1245 | 3% | 0% | 17 |
6 | LEUKEMIA RESEARCH | 1236 | 2% | 0% | 12 |
7 | LEUKEMIA | 1159 | 2% | 0% | 13 |
8 | CLINICAL CANCER RESEARCH | 885 | 3% | 0% | 16 |
9 | CANCER RESEARCH | 876 | 4% | 0% | 26 |
10 | ANTI-CANCER DRUGS | 779 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRYOSTATIN | 2948119 | 14% | 67% | 84 | Search BRYOSTATIN | Search BRYOSTATIN |
2 | BRYOSTATIN 1 | 2832394 | 14% | 68% | 79 | Search BRYOSTATIN+1 | Search BRYOSTATIN+1 |
3 | APLYSIATOXIN | 303331 | 2% | 52% | 11 | Search APLYSIATOXIN | Search APLYSIATOXIN |
4 | BRYOSTATIN I | 210584 | 1% | 100% | 4 | Search BRYOSTATIN+I | Search BRYOSTATIN+I |
5 | MARINE BRYOZOAN | 198428 | 1% | 54% | 7 | Search MARINE+BRYOZOAN | Search MARINE+BRYOZOAN |
6 | BUGULA NERITINA | 181556 | 2% | 27% | 13 | Search BUGULA+NERITINA | Search BUGULA+NERITINA |
7 | BRYOSTATIN 11 | 157938 | 1% | 100% | 3 | Search BRYOSTATIN+11 | Search BRYOSTATIN+11 |
8 | APLOG 1 | 105292 | 0% | 100% | 2 | Search APLOG+1 | Search APLOG+1 |
9 | D ISOBUTYL LACTATE | 105292 | 0% | 100% | 2 | Search D+ISOBUTYL+LACTATE | Search D+ISOBUTYL+LACTATE |
10 | DABIS MALEATE | 105292 | 0% | 100% | 2 | Search DABIS+MALEATE | Search DABIS+MALEATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HALE, KJ , MANAVIAZAR, S , (2010) NEW APPROACHES TO THE TOTAL SYNTHESIS OF THE BRYOSTATIN ANTITUMOR MACROLIDES.CHEMISTRY-AN ASIAN JOURNAL. VOL. 5. ISSUE 4. P. 704-754 | 101 | 63% | 62 |
2 | RUAN, BF , ZHU, HL , (2012) THE CHEMISTRY AND BIOLOGY OF THE BRYOSTATINS: POTENTIAL PKC INHIBITORS IN CLINICAL DEVELOPMENT.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 16. P. 2652-2664 | 77 | 75% | 24 |
3 | KORTMANSKY, J , SCHWARTZ, GK , (2003) BRYOSTATIN-1: A NOVEL PKC INHIBITOR IN CLINICAL DEVELOPMENT.CANCER INVESTIGATION. VOL. 21. ISSUE 6. P. 924-936 | 85 | 79% | 90 |
4 | KRAFT, MB , POUDEL, YB , KEDEI, N , LEWIN, NE , PEACH, ML , BLUMBERG, PM , KECK, GE , (2014) SYNTHESIS OF A DES-B-RING BRYOSTATIN ANALOGUE LEADS TO AN UNEXPECTED RING EXPANSION OF THE BRYOLACTONE CORE.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 136. ISSUE 38. P. 13202 -13208 | 50 | 85% | 9 |
5 | KETCHAM, JM , VOLCHKOV, I , CHEN, TY , BLUMBERG, PM , KEDEI, N , LEWIN, NE , KRISCHE, MJ , (2016) EVALUATION OF CHROMANE-BASED BRYOSTATIN ANALOGUES PREPARED VIA HYDROGEN-MEDIATED C-C BOND FORMATION: POTENCY DOES NOT CONFER BRYOSTATIN-LIKE BIOLOGY.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 138. ISSUE 40. P. 13415 -13423 | 60 | 64% | 0 |
6 | ANDREWS, IP , KETCHAM, JM , BLUMBERG, PM , KEDEI, N , LEWIN, NE , PEACH, ML , KRISCHE, MJ , (2014) SYNTHESIS OF SECO-B-RING BRYOSTATIN ANALOGUE WN-1 VIA C-C BOND-FORMING HYDROGENATION: CRITICAL CONTRIBUTION OF THE B-RING IN DETERMINING BRYOSTATIN-LIKE AND PHORBOL 12-MYRISTATE 13-ACETATE-LIKE PROPERTIES.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 136. ISSUE 38. P. 13209 -13216 | 52 | 71% | 5 |
7 | CLAMP, A , JAYSON, GC , (2002) THE CLINICAL DEVELOPMENT OF THE BRYOSTATINS.ANTI-CANCER DRUGS. VOL. 13. ISSUE 7. P. 673 -683 | 56 | 84% | 64 |
8 | TROST, BM , FRONTIER, AJ , THIEL, OR , YANG, HB , DONG, GB , (2011) TOTAL SYNTHESIS OF BRYOSTATINS: THE DEVELOPMENT OF METHODOLOGY FOR THE ATOM-ECONOMIC AND STEREOSELECTIVE SYNTHESIS OF THE RING C SUBUNIT.CHEMISTRY-A EUROPEAN JOURNAL. VOL. 17. ISSUE 35. P. 9762 -9776 | 57 | 68% | 5 |
9 | LU, Y , KRISCHE, MJ , (2009) CONCISE SYNTHESIS OF THE BRYOSTATIN A-RING VIA CONSECUTIVE C-C BOND FORMING TRANSFER HYDROGENATIONS.ORGANIC LETTERS. VOL. 11. ISSUE 14. P. 3108 -3111 | 50 | 79% | 14 |
10 | BALL, M , BARON, A , BRADSHAW, B , DUMEUNIER, R , O'BRIEN, M , THOMAS, EJ , (2016) THE EVOLUTION OF A STEREOSELECTIVE SYNTHESIS OF THE C1-C16 FRAGMENT OF BRYOSTATINS.ORGANIC & BIOMOLECULAR CHEMISTRY. VOL. 14. ISSUE 40. P. 9650 -9681 | 45 | 71% | 0 |
Classes with closest relation at Level 1 |